8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

T.Sugiyama; S.Kumagai; T.Shouji; H.Michimae; N.Katsumata; H.Tsuda; D.Aoki; F.Terauchi; T.Jobo; M.Yasuda

首页> 外文期刊>European Journal of Cancer Supplements >8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

【24h】

8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

机译：8021贫血对紫杉醇-卡铂联合疗法治疗的上皮性卵巢癌（II-IV期）患者无进展生存的影响：日本妇科肿瘤学小组（JGOG3016-A）JGOG3016试验的回顾性分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第2期|共1页
作者
T.Sugiyama; S.Kumagai; T.Shouji; H.Michimae; N.Katsumata; H.Tsuda; D.Aoki; F.Terauchi; T.Jobo; M.Yasuda;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Does severe anemia caused by dose-dense paclitaxel-Carboplatin combination therapy have an effect on the survival of patients with epithelial ovarian cancer? Retrospective analysis of the Japanese gynecologic oncology group 3016 trial. [J] . Kumagai S, Sugiyama T, Shoji T, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2011,第9期

机译：剂量密集的紫杉醇-卡铂联合疗法引起的严重贫血对上皮性卵巢癌患者的生存有影响吗？日本妇科肿瘤学组3016试验的回顾性分析。
2. Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016). [J] . K Harano, F Terauchi, N Katsumata, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第1期

机译：每周剂量密集的紫杉醇和卡铂与常规紫杉醇和卡铂作II-IV期卵巢癌一线治疗的随机III期试验的生活质量结果：日本妇科肿瘤学小组试验（JGOG3016）。
3. A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) [J] . Cynthia A. Thomson, Tracy E. Crane, Austin Miller, Contemporary clinical trials . 2016,第1期

机译：治疗II-IV阶段卵巢癌妇女饮食和身体活动的随机试验：卵巢癌增强生存（Lives）的生活方式干预的理由和设计：NRG肿瘤学/妇科肿瘤学组（GOG-225）
4. An open-label randomized phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian fallopian tube or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale design and methods of the Japanese Gynecologic Oncology Group study JGOG3023 [O] . Tadahiro Shoji, Shinichi Komiyama, Junzo Kigawa, 2018

机译：一项开放性随机II期临床试验评估接受或不接受贝伐单抗治疗的标准治疗在铂耐药的上皮性卵巢癌输卵管或原发性腹膜癌患者中接受过贝伐单抗治疗的一线或铂类敏感性的疗效和安全性卵巢癌：日本妇科肿瘤小组研究JGOG3023的原理设计和方法
5. An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023 [O] . Tadahiro Shoji, Shinichi Komiyama, Junzo Kigawa, 2018

机译：在铂抗性上皮卵巢卵巢卵巢卵巢卵巢卵巢，输卵管或原发性腹膜癌症患者中使用Bevacizumab用于前线或铂敏感的抗蜂巢蛋白，或没有Bevacizumab的疗效和安全性评估患者的疗效和安全性卵巢癌：日本妇科肿瘤学群体研究JGOG3023的理由，设计和方法

8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

著录项

相似文献

相关主题

期刊订阅